沙丁胺醇雾化吸入联合苏黄止咳胶囊治疗慢性阻塞性肺疾病急性加重期的效果

Abstract
Figure/Table
References (14)
Related Citation (15)

Download: PDF (0 KB) HTML (32 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of aerosol inhalation of Salbutamol combined with Suhuang Zhike Capsules in acute exacerbation of chronic obstructive pulmonary disease (AECOPD).Methods A total of 128 cases with AECOPD treated in our hospital from April 2016 to April 2018 were selected as the subjects,and divided into observation group and control group,with 64 cases in each group.The control group was treated with Salbutamol inhalation,and the observation group was treated with Suhuang Zhike Capsules on the basis of the control group.The curative effect,improvement of pulmonary function and incidence of adverse reactions between the two groups were compared.Results The total effective rate of treatment in the observation group was higher than that in the control group (P＜0.05).The values of forced expiratory volume in one second(FEV1),FEV1/FVC and peak expiratory flowrate(PEF)in the observation group were higher than those in the control group (P＜0.05).There was no significant difference in the total incidence of adverse reactions between the two groups(P＞0.05).Conclusion Salbutamol atomization inhalation combined with Suhuang Zhike Capsules in the treatment of AECOPD can achieve significant effect,improve the pulmonary function.It has good safety and is worthy of clinical application.

Key words： Salbutamol Chronic obstructive pulmonary disease Suhuang Zhike Capsules Albutamol inhalation Pulmonary function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Xiao-qing
	CHEN Guang
	CHEN Xiao-yun
	LIU Hou-qiang

Cite this article:

YANG Xiao-qing,CHEN Guang,CHEN Xiao-yun, et al. Effect of aerosol inhalation of Salbutamol combined with Suhuang Zhike Capsules in acute exacerbation of chronic obstructive pulmonary disease[J]. 中国当代医药, 2019, 26(5): 47-49.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2019/V26/I5/47

[1]	Chatila WM，Thomashow BM，Minai OA，et al.Comorbidities in chronic obstructive pulmonary disease[J].Proc Am Thorac Soc，2016，52（11）：547.
[2]	王伟镇，林泽怀，朱国炼.不同氧气雾化吸入方法治疗慢性阻塞性肺疾病急性加重期患者的疗效观察[J].海南医学，2017，28（4）：639-641.
[3]	历鹍.冬虫夏草在慢性阻塞性肺疾病治疗中的临床应用[J].中外医学研究，2017，15（26）：148-149.
[4]	Washko GR，Fan VS，Ramsey SD，et al.The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations[J].Am J Resp Crit，2016，177（2）：164-169.
[5]	李爱菊.布地奈德联合沙丁胺醇混悬液氧驱雾化吸入治疗高原地区COPD急性加重期的临床观察及护理[J].青海医药杂志，2013，11（11）：34-35.
[6]	程燕雯，杜辛歌，王迎难，等.沙丁胺醇联合布地奈德对重症肺炎合并呼吸窘迫综合征患者心功能及血气分析的影响[J].疑难病杂志，2016，15（4）：362-365.
[7]	张艳霞.罗氟司特联合多索茶碱治疗慢性阻塞性肺疾病的临床效果观察[J].中外医学研究，2018，16（31）：21-23.
[8]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2007年修订版）[J].中华结核和呼吸杂志，2007，46（1）：8-17.
[9]	Zeki AA，Jarjour NN.The asthma-chronic obstructive pulmonary disease overlap syndrome：a new take on an old concept[J].Ann Am Thorac Soc，2016，13（9）：1440-1442.
[10]	苏春燕，范吉平，刘祖发，等.慢性阻塞性肺疾病急性加重期机械通气患者中医证候与APACHEⅡ评分的相关研究[J].中华中医药杂志，2017，13（10）：4370-4372.
[11]	杨振英，王亚坤，周礼清，等.糖皮质激素类联合肾上腺素能β激动剂对慢性阻塞性肺疾病急性加重期患者的疗效分析[J].安徽医药，2018，22（1）：151-155.
[12]	赵翔宇.硫酸沙丁胺醇与噻托溴铵联合治疗对AECOPD患者 CysC、hs-CRP和 PA 的影响[J].现代医学，2016，21（4）：479-483.
[13]	Cosío BG，Shafiek H，Iglesias A，et al.Oral low-dose theophylline on top of inhaled fluticasone-salmeterol does not reduce exacerbations in patients with severe COPD：a pilot clinical trial[J].Chest，2016，150（1）：123-130.
[14]	王沁，宋德胤.布地奈德联合沙丁胺醇雾化吸入治疗AECOPD的疗效及对肺功能相关指标的影响[J].实用临床医药杂志，2016，20（7）：38-40.